These medications were initially developed and approved for the treatment of type 2 diabetes.6 However, during clinical trials and subsequent use, it became evident that they also led to significant weight loss in many individuals.9 This observation paved the way for some GLP-1 medications to also be approved specifically for weight management in individuals with obesity or overweight who also have weight-related health conditions
MeAgains GLP-1 app offers personalized protein goals and practical tracking tools to support a balanced approach to weight management
According to the White House fact sheet released that day, this represents the most significant actions ever taken by our Federal government to lower prescription drug prices. The agreements establish a voluntary pilot program that will begin in mid-2026, representing the first time Medicare will cover GLP-1 medications specifically for obesity, though only for patients meeting defined comorbidity criteria
Heres everything patients should know before adding L-carnitine injections to their wellness or weight-loss plan
Others are unlicensed compounds sold on the grey market - and the gap between those two categories is significant in terms of safety, legality, and effectiveness